证券代码：688265 证券简称：南模生物 公告编号：2026-003 上海南方模式生物科技股份有限公司 第四届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 上海南方模式生物科技股份有限公司（以下简称"公司"）第四届董事会第五次会议于2026年1月29日以 现场结合通讯方式召开。本次会议的通知已于2026年1月26日以电子邮件方式送达全体董事。本次会议 由董事长费俭先生召集并主持，会议应参会董事11人，实际出席董事11人，其中独立董事4人，公司高 级管理人员列席了会议。本次会议的召集、召开符合《中华人民共和国公司法》等法律法规及《上海南 方模式生物科技股份有限公司章程》的相关规定。 二、董事会会议审议情况 本次会议以记名投票方式表决，审议并通过了以下议案： 1、审议通过《关于使用自有闲置资金进行现金管理的议案》 表决结果：同意11票，反对0票，弃权0票 2、审议通过《关于补选公司第四届董事会非独立董事的议案》 鉴于公司董事杨利华女士辞去公司第四届董事会非独立董事职务，为保 ...

Core Viewpoint - The 2025 performance forecasts for companies listed on the Sci-Tech Innovation Board show promising results, with nearly 250 companies disclosing their earnings, and around 50% of them expected to be profitable, indicating a recovery in market demand and growth in emerging industries such as semiconductors, biomedicine, and artificial intelligence [1] Group 1: Company Performance - 125 companies are expected to achieve profitability, with 67 companies forecasting positive growth in net profit year-on-year, and 29 companies anticipating a profit increase of over 100% [1][2] - Shanghai Yizhong leads with a projected net profit increase of 760.18% to 903.54%, followed by Zhenlei Technology and Baiwei Storage with expected increases of 529.64% to 642.26% and 427.19% to 520.22%, respectively [2] - Baiao Saitu anticipates a significant net profit increase of 384.26% to 443.88%, driven by its advanced antibody platform and collaborations with major companies [4] Group 2: Industry Trends - The semiconductor, biomedicine, and AI sectors are experiencing a surge in demand, contributing to the overall positive performance of the Sci-Tech Innovation Board companies [1][3] - Companies like Shijia Photon are benefiting from the AI boom, with a projected net profit increase of 425.95% due to rising orders in the data communication market [5] - The PCB and CCL industries are also seeing growth, with companies like Shengyi Electronics and Nanya New Materials expecting substantial profit increases due to high-quality orders and market expansion [6][7] Group 3: International Expansion - Many companies are actively pursuing international markets, with Pioneering Technology expecting a net profit of 62 million to 86 million yuan, a year-on-year increase of 50.82% to 109.21%, driven by international demand for energy storage solutions [3] - The internationalization strategy is becoming a key path for high-quality development among listed companies [3]

Core Viewpoint - Nanhua Biopharmaceutical Co., Ltd. has officially terminated its major asset restructuring plan after nearly six months of planning due to a lack of consensus among the parties involved in the transaction [1] Group 1: Company Background and Performance Challenges - The company, originally listed as Hong Kong and Macau Industry in 1992, has undergone multiple ownership changes and name changes, finally being renamed Nanhua Biopharmaceutical in 2015 to enter the biomedicine sector [2] - The company has two main businesses: biomedicine (stem cell and immune cell storage) and energy conservation and environmental protection, but its performance has been inconsistent, with revenue still heavily reliant on cell storage [2] - The company has oscillated between being under special treatment (ST) and being delisted, facing continuous losses from 2014 to 2015, leading to its first ST designation in 2016, and again facing ST status in 2019 due to two consecutive years of losses [2] Group 2: Termination of Restructuring and Financial Impact - The company announced the termination of its plan to acquire a 51% stake in Hunan Huize Biopharmaceutical Technology Co., Ltd. due to the inability to reach an agreement on the transaction terms, with the termination not expected to have a significant adverse impact on its operations or financial status [3][4] - The company committed to not planning any major asset restructuring for at least one month following the announcement [4] Group 3: Financial Forecast and Recovery - Alongside the termination announcement, the company projected its 2025 revenue to be between 385 million to 425 million yuan, a significant increase from approximately 130 million yuan in the previous year [5] - The company expects to achieve a net profit attributable to shareholders of between 28.5 million to 32.5 million yuan in 2025, marking a turnaround from a loss of 19.846 million yuan in the same period last year [6] - The recovery is primarily driven by the acquisition of Loudi Jinhong New Materials Co., Ltd., which has enhanced revenue from resource recycling businesses, rather than the terminated biopharmaceutical acquisition [6][7]

Core Viewpoint - Shanghai is set to achieve a GDP of 5.67 trillion yuan by 2025, reflecting a year-on-year growth of 5.4%, as it aims to enhance its role as an international technology innovation center [3]. Economic Growth and Structure - Over the past five years, Shanghai's economy has surpassed the 5 trillion yuan mark, adding over 1 trillion yuan, equivalent to creating a new "trillion-level city" [3]. - The city is focusing on enhancing its economic structure and quality during the 14th Five-Year Plan period, aiming for a new phase of development [3][4]. Key Industries and Innovations - Shanghai's leading industries, including integrated circuits, artificial intelligence, and biomedicine, are projected to see significant growth. The integrated circuit industry is expected to generate over 488 billion yuan in revenue by 2025, doubling in size over five years [5]. - The artificial intelligence sector is anticipated to exceed 550 billion yuan, with a year-on-year growth rate of over 30% [5]. - By 2025, Shanghai's three leading industries are expected to achieve an industrial output value growth of 9.6%, surpassing 2 trillion yuan for the first time [5]. Investment and Business Environment - Shanghai has seen an average of over 5,800 new foreign-funded enterprises established annually since the 14th Five-Year Plan, reinforcing its position as a major global trade hub [21]. - The city has implemented various measures to optimize its investment environment, including policies to support foreign R&D centers and enhance their capabilities [24]. Export and Trade Performance - In 2025, Shanghai's total import and export volume is expected to exceed 3 trillion USD over five years, with exports growing significantly, including a 10.8% increase in overall exports [26]. - The export of high-end machine tools, industrial robots, and electric vehicles has seen substantial growth, with industrial robots' exports increasing by over 40% [26]. Regional Development and Innovation - The Pudong New Area, accounting for one-third of Shanghai's economic output, is focusing on upgrading its industrial structure and fostering innovation [12][14]. - The area is actively reducing low-end capacity while promoting the rapid development of core industrial clusters [14][15].

Core Viewpoint - Shanghai is leveraging innovation as a driving force for economic transformation, aiming for a GDP of 5.67 trillion yuan by 2025, with a growth rate of 5.4% [1] Economic Growth and Structure - Shanghai's economy has crossed the 5 trillion yuan threshold in the past five years, adding over 1 trillion yuan, equivalent to creating a new "trillion-level city" [2] - The city is expected to see significant growth in its three leading industries: integrated circuits, artificial intelligence, and biomedicine, with industrial output projected to exceed 2 trillion yuan by 2025, growing by 9.6% year-on-year [3][4] Industry Development - The integrated circuit industry is projected to generate over 488 billion yuan in revenue by 2025, doubling in size over five years, while the AI industry is expected to exceed 550 billion yuan, growing over 30% [3] - Shanghai's strategic emerging industries are anticipated to grow by 6.5% year-on-year, accounting for 45% of the total industrial output [4] Investment and Foreign Capital - Shanghai has seen an average of over 5,800 new foreign-funded enterprises established annually since the 14th Five-Year Plan began [11] - The city is home to 1,076 regional headquarters and 636 foreign R&D centers, maintaining its status as the most concentrated city for multinational company headquarters in mainland China [11] Innovation Ecosystem - The "Shanghai Silicon Alley" in Changning District has attracted nearly 900 innovative enterprises, forming micro-ecosystems around sectors like integrated circuits [8] - The city has continuously improved its business environment, with 22 indicators in the World Bank's business environment assessment reaching global best levels, surpassing cities like Singapore and New York [9] Future Prospects - Shanghai aims to transform its new quality productivity into a competitive advantage for the future, focusing on new technologies, factors, business models, and scenarios [12]

Core Viewpoint - The company Baipusais announced an expected net profit attributable to shareholders of 160 million to 190 million yuan for 2025, indicating a year-on-year growth of 29.21% to 53.43% [1] - The projected operating revenue is expected to reach 837 million yuan, reflecting an approximate year-on-year increase of 30% [1] Financial Performance - Expected net profit for 2025: 160 million to 190 million yuan [1] - Year-on-year growth in net profit: 29.21% to 53.43% [1] - Projected operating revenue for 2025: 837 million yuan [1] - Year-on-year growth in operating revenue: approximately 30% [1]

Core Viewpoint - The company, Novogene, announced an expected net loss attributable to the parent company of between 20 million to 10 million yuan for the fiscal year 2025 [2] Group 1 - The projected net loss for 2025 is estimated to be between -20 million yuan and -10 million yuan [2]

Core Viewpoint - The company positions itself as an "integrated service provider and general operator for park innovation ecology," focusing on three leading industries: integrated circuits, biomedicine, and artificial intelligence [1] Group 1: Investment Strategy - The company is actively building an industrial investment matrix around key industries, enhancing its investment attributes towards chain-leading enterprises, unicorns, and gazelle companies [1] - It has successfully promoted investments in well-known companies such as ByteDance, Jiangbolong, Biren Technology, and SenseTime [1] Group 2: Investment Platforms and Focus Areas - The "Shanghai Lingang Ciyuan Venture Capital Fund" serves as the core platform for the company, which emphasizes strengthening its layout and cultivation of cutting-edge and disruptive technologies [1] - The company is increasing its investment support for key industries within the park, concentrating on forward-looking layouts for potential "hard tech" enterprises [1]

Core Viewpoint - The article highlights the challenges of technology transfer and its impact on industrial upgrading, emphasizing the collaborative efforts in Tianjin's Beijing-Tianjin Zhongguancun Science and Technology City to bridge the gap between innovation and industry [3]. Group 1: Technology and Innovation - The first large-scale "intelligent pressure coupling equipment" is being installed in Huainan coal mine, marking a significant step in applying theoretical advancements to practical use [3]. - The project involves collaboration among various sectors, including enterprises, universities, and research institutions, to form a synergistic innovation consortium that accelerates technology transfer [3]. - The equipment aims to address the long-standing issue of heat hazards in deep mining, which has historically relied on imported technology, thus enhancing safety and efficiency in resource extraction [3]. Group 2: Collaborative Ecosystem - The Beijing-Tianjin Zhongguancun Science and Technology City is focused on promoting collaborative technological innovation and integration of industrial systems, supporting enterprises in enhancing R&D efforts [4]. - The intelligent connected bus demonstration line in Baodi District exemplifies successful technology transfer, utilizing Tsinghua University's advancements in smart vehicles to create a seamless operation between vehicles, roads, and cloud systems [4]. - Companies like Zhongke Baike (Tianjin) Biopharmaceutical Co., Ltd. have benefited from the local ecosystem, achieving over 20 patents and establishing a comprehensive R&D system from gene discovery to formulation research [4]. Group 3: Future Development - The Deputy District Mayor of Baodi emphasizes the ongoing improvement of the innovation ecosystem in the Beijing-Tianjin Zhongguancun Science and Technology City, highlighting the accelerating effects of innovation aggregation [5]. - Future plans include leveraging the comparative advantages of the technology city in terms of space, cost, public services, and application scenarios to further promote technology transfer and contribute to the construction of an international innovation center in the Beijing-Tianjin-Hebei region [5].

Core Viewpoint - Baipusais (301080.SZ) has disclosed its performance forecast for the year 2025, expecting a net profit attributable to shareholders of between 160 million yuan and 190 million yuan, representing a year-on-year growth of 29.21% to 53.43% [1] Summary by Category - **Net Profit Forecast** - The company anticipates a net profit of 160 million to 190 million yuan for 2025, indicating a significant increase compared to the previous year [1] - **Adjusted Net Profit** - The forecasted net profit, excluding non-recurring gains and losses, is expected to be between 155 million and 185 million yuan, reflecting a year-on-year growth of 30.13% to 55.31% [1]